All Articles on Trial
Researchers begin trial of C. diff vaccineKPWHRI is inviting Kaiser Permanente Washington members age 65 and older to take part.
Researchers begin trial of nasal spray COVID-19 vaccineKPWHRI is taking part in a clinical trial of a nasal COVID-19 vaccine developed by Boost Biopharma Inc.
Scientists begin trial of combined COVID-19 and flu vaccineKPWHRI is recruiting Kaiser Permanente Washington members to take part.
Vaccine program recruiting volunteers in Seattle areaKPWHRI’s vaccine registry was the first to enroll participants in a clinical trial of a COVID-19 vaccine.
Clinical trial will evaluate mpox vaccine for adolescentsThe NIH-sponsored trial will help inform decisions about vaccine approval for 12- to 17-year-olds.
Researchers begin trial for mRNA flu vaccineThe investigational vaccine is in the third phase of trials and targets flu strains expected to circulate this winter.
Gene-edited malaria vaccine warrants further studyEncouraging immune-response and safety data emerge from preliminary human test of genetically attenuated parasite vaccine.
